X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Finland Pharmaceutical Companies (2024 - 2029)

Several pharmaceutical companies are making significant strides in the industry. These firms are engaged in the research, development, production, and distribution of various medicines and healthcare products. Their operations span across multiple continents, contributing to the global healthcare sector. The contributions of these corporations are pivotal in advancing medical science, improving patient outcomes, and enhancing overall public health.

Home Market Analysis Healthcare Research Pharmaceuticals Research Finland Pharmaceutical Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Finland Pharmaceutical Market

This report lists the top Finland Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Finland Pharmaceutical industry.

  1. Abbvie

  2. AstraZeneca

  3. Bayer

  4. C.H. Boehringer Sohn

  5. GlaxoSmithKline

*Disclaimer: Top companies sorted in no particular order

Finland Pharmaceutical Market Major Players

Finland Pharmaceutical Market Concentration

Finland Pharmaceutical Market Concentration

Finland Pharmaceutical Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions & Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

      1. 4.1.1 Healthcare Expenditure

      2. 4.1.2 Pharmaceutical Imports and Exports

      3. 4.1.3 Epidemiology Data For key Diseases

      4. 4.1.4 Regulatory Landscape/Regulatory Bodies

      5. 4.1.5 Licensing and Market Authorization

      6. 4.1.6 Pipeline Analysis

        1. 4.1.6.1 By Phase

        2. 4.1.6.2 By Sponsor

        3. 4.1.6.3 By Disease

      7. 4.1.7 Statistical Overview

        1. 4.1.7.1 Number of Hospitals

        2. 4.1.7.2 Employment in the Pharmaceutical Sector

        3. 4.1.7.3 R&D Expenditure

      8. 4.1.8 Ease of Doing Business

    2. 4.2 Market Drivers

      1. 4.2.1 Significant research and development programs

      2. 4.2.2 Rising Incidence of Chronic Disease

    3. 4.3 Market Restraints

      1. 4.3.1 Highly Expensive Patented Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD )

    1. 5.1 By ATC/Therapeutic Class

      1. 5.1.1 Alimentary Tract and Metabolism

      2. 5.1.2 Blood and Blood Forming Organs

      3. 5.1.3 Cardiovascular System

      4. 5.1.4 Dermatologicals

      5. 5.1.5 Genito Urinary System and Sex Hormones

      6. 5.1.6 Systemic Hormonal Preparations,

      7. 5.1.7 Antiinfectives For Systemic Use

      8. 5.1.8 Antineoplastic and Immunomodulating Agents

      9. 5.1.9 Musculo-Skeletal System

      10. 5.1.10 Nervous System

      11. 5.1.11 Antiparasitic Products, Insecticides and Repellents

      12. 5.1.12 Respiratory System

      13. 5.1.13 Sensory Organs

      14. 5.1.14 Other ATC/Therapeutic Classes

    2. 5.2 By Prescription Type

      1. 5.2.1 Prescription Drugs (Rx)

        1. 5.2.1.1 Branded

        2. 5.2.1.2 Generic

      2. 5.2.2 OTC Drugs

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc.

      2. 6.1.2 AstraZeneca plc

      3. 6.1.3 Bayer AG

      4. 6.1.4 C.H. Boehringer Sohn AG & Ko. KG

      5. 6.1.5 GlaxoSmithKline plc

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 Bristol Myers Squibb Company

      8. 6.1.8 Eli Lilly and Company

      9. 6.1.9 Merck & Co., Inc.

      10. 6.1.10 Sanofi S.A.

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Finland Pharmaceutical Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Finland Pharmaceutical Market Companies Summary

The Finnish pharmaceutical market is expected to see growth due to collaboration between healthcare and pharmaceutical operators to prevent medication shortages during the COVID-19 pandemic. These businesses assessed the pandemic's impact on production and supply chains, working closely with pharmaceutical producers and importers. Authorities kept a close eye on the situation in collaboration with other industry companies, with regular updates on issues being exchanged. European medical authorities in Finland supported the continued availability of medicines, and the development of effective treatments and vaccines. A Finnish academic lab also contributed to the market growth by working on a nasal spray vaccine for COVID-19. The pharmaceutical market in Finland is also set to benefit from increasing spending on pharmaceutical products, indicating a high demand for drugs. This is expected to fuel market growth. Companies are urged to develop innovative drugs for treating various diseases, which is expected to augment the market growth over the forecast period. The government and institutions are also focusing on accelerating drug development initiatives in the country, which is expected to fuel market growth. This includes partnerships with universities and other companies to improve cancer treatments. There is also a growing number of grants and project launches by companies, increasing drug research and development activities in the country. This is anticipated to propel the growth of the pharmaceutical market over the forecast period.

Explore More

Finland Pharmaceutical Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 AbbVie Inc.

      2. 1.1.2 AstraZeneca plc

      3. 1.1.3 Bayer AG

      4. 1.1.4 C.H. Boehringer Sohn AG & Ko. KG

      5. 1.1.5 GlaxoSmithKline plc

      6. 1.1.6 F. Hoffmann-La Roche AG

      7. 1.1.7 Bristol Myers Squibb Company

      8. 1.1.8 Eli Lilly and Company

      9. 1.1.9 Merck & Co., Inc.

      10. 1.1.10 Sanofi S.A.

    2. *List Not Exhaustive

Finland Pharmaceutical Companies FAQs

AbbVie Inc., AstraZeneca plc, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG and GlaxoSmithKline plc are the major companies operating in the Finland Pharmaceutical Market.

Finland Pharmaceutical Market Report Snapshots

Finland Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)